QMSMEDI150.00

QMS Medical Allied Services Limited

· Pharma & Health
AnnualQuarterly₹ CroreMcap ₹290 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations156.0172.9267.0
Other Income1.71.11.8
Total Income157.7173.9268.8
Expenses
+ Purchases of Stock-in-Trade81.3100.1154.6
+ Changes in Inventories0.3-7.5-16.9
+ Employee Benefit Expense9.615.229.4
+ Finance Costs4.66.610.0
+ Depreciation & Amortisation3.83.96.4
+ Other Expenses39.439.259.0
Total Expenses139.1157.5242.5
EBITDA25.425.940.9
EBIT21.621.934.5
Profit
PBT before Exceptional Items18.716.426.3
Pretax Income18.716.426.3
+ Current Tax5.54.77.1
+ Deferred Tax-0.5-0.20.2
Tax Expense5.04.57.2
Net Income13.711.919.0
Per Share
Basic EPS6.775.408.72
Diluted EPS6.775.408.72
Profit Build-up — Alternate / Pre-Ind-AS Tags
PBT before Exceptional & Extraordinary Items18.716.4
+ Adjustments to Profit / (Loss)3.58.8
Profit for the Period before Minority Interest13.711.9
Continuing & Discontinued Operations
Profit from Continuing Operations13.711.9
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit74.480.2129.3
Gross Margin %47.7046.4248.44
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)18.716.426.3
Net Income Adj (tax-effected)13.711.919.0
EPS Adj6.775.408.72
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value10.0010.0010.00
Filed Debt Equity0.000.00
Filed Dscr0.020.02
Filed Iscr0.040.05
Paid Up Equity Capital17.919.319.3
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.